Activity and Adverse Events of Actinium-225-PSMA-617 in Advanced Metastatic Castration-resistant Prostate Cancer After Failure of Lutetium-177-PSMA[Formula presented]
Publikation: Beitrag in Fachzeitschrift › Artikel › Begutachtung
161Zitate
(Scopus)
Fingerprint
Untersuchen Sie die Forschungsthemen von „Activity and Adverse Events of Actinium-225-PSMA-617 in Advanced Metastatic Castration-resistant Prostate Cancer After Failure of Lutetium-177-PSMA[Formula presented]“. Zusammen bilden sie einen einzigartigen Fingerprint.